
Identifying cell subpopulations conferring unfavourable prognosis in cancer holds clinical significance. The study sought to identify prognostic cell subsets and develop a novel, prognostic signature for head-neck squamous cell carcinoma (HNSCC). The study model derived from integrative analyses of single‐cell and bulk RNA‐sequencing is a novel, robust prognostic biomarker for HNSCC.
Like
Save
Share